Damon R. Reed, MD

In my research, I am exploring how to best combine and sequence therapies to maximize patient outcomes. This includes targeted therapies that take aim at the molecular changes fueling cancer growth, as well as conventional chemotherapy, immunotherapy, and the timely incorporation of surgery and radiation therapy. This is a revolutionary field in cancer called precision oncology. I am also involved in early-phase clinical trials, which assess new therapies in people with cancer.

When I meet with a young patient and their family members, I first teach them what I know about cancer. I describe a range of options, listen to them, and answer all of their questions. I then provide a recommendation about their care based on the risks and potential benefits for the patient and family. In addition to caring for patients and doing research, I am the Vice Chair of the Bone Tumor Committee for the Children’s Oncology Group. I am also the Vice President of the Connective Tissue Oncology Society, an international society of sarcoma specialists, and will be the group’s President in 2024. I chose this field to make a difference for the extraordinary and inspiring young people I care for, who want and deserve better therapies. I think we are on the cusp of improving outcomes for them and their families. I am excited to be a part of the world-class team at MSK Kids and will collaborate with others across the institution to develop more dynamic approaches to the care of young people with sarcomas and other pediatric solid tumors.